Finite-time dynamics of the fractional-order epidemic model: Stability, synchronization, and simulations
Chaos, Solitons & Fractals: X · 2024-12 · 13 · 100118
DOI: 10.1016/j.csfx.2024.100118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chaos, Solitons & Fractals: X, 2024-12. Verfasst von Iqbal M. Batiha und 5 weiteren Autor:innen. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of this paper is to explore finite-time synchronization in a specific subset of fractional-order epidemic reaction–diffusion systems. Initially, we introduce a new lemma for finite-time stability, which extends existing criteria and builds upon previous discoveries. Following this, we design effective state-dependent linear controllers. By utilizing a Lyapunov function, we derive new sufficient conditions to ensure finite-time synchronization within a predefined time frame. Lastly, we present numerical simulations to demonstrate the applicability and effectiveness of the proposed technique.
Zitieren
APA
Batiha, I. M., Ogilat, O., Bendib, I., Ouannas, A., Jebril, I. H., & Anakira, N. (2024). Finite-time dynamics of the fractional-order epidemic model: Stability, synchronization, and simulations. Chaos, Solitons & Fractals: X, 13, 100118. https://doi.org/10.1016/j.csfx.2024.100118
Vancouver
Batiha IM, Ogilat O, Bendib I, Ouannas A, Jebril IH, Anakira N. Finite-time dynamics of the fractional-order epidemic model: Stability, synchronization, and simulations. Chaos, Solitons & Fractals: X. 2024;13:100118. doi:10.1016/j.csfx.2024.100118
BibTeX
@article{Batiha2024,
author = {Batiha, Iqbal M. and Ogilat, Osama and Bendib, Issam and Ouannas, Adel and Jebril, Iqbal H. and Anakira, Nidal},
title = {Finite-time dynamics of the fractional-order epidemic model: Stability, synchronization, and simulations},
journal = {Chaos, Solitons & Fractals: X},
year = {2024},
volume = {13},
pages = {100118},
doi = {10.1016/j.csfx.2024.100118}
}
EUVIMED